Article Details
Retrieved on: 2019-12-14 01:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Vanguard Group</b> Inc. acquired a new position in shares of Stoke Therapeutics in the 2nd quarter valued at $2,917,000. Institutional investors ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here